摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Acetyl-cyclobutanol | 30494-01-0

中文名称
——
中文别名
——
英文名称
3-Acetyl-cyclobutanol
英文别名
1-(3-Hydroxycyclobutyl)ethan-1-one;1-(3-hydroxycyclobutyl)ethanone
3-Acetyl-cyclobutanol化学式
CAS
30494-01-0
化学式
C6H10O2
mdl
——
分子量
114.144
InChiKey
PVIMOZWSCYVZBM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.2
  • 重原子数:
    8
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • AROMATIC 5-MEMBERED HETEROCYCLIC DERIVATIVE HAVING TRPV4-INHIBITING ACTIVITY
    申请人:Shionogi & Co., Ltd.
    公开号:US20150038483A1
    公开(公告)日:2015-02-05
    The present invention is related to a compound represented by formula (I) wherein R 1 is a hydrogen atom, substituted or unsubstituted alkyl, substituted or unsubstituted aromatic carbocyclyl, or the like; X is —N(R 3 )—, —O—, or —S—; Y is ═C(R 4 )—, or ═N—; Z is —N(R 7 )—, —O—, or —S—; R 2 is substituted or unsubstituted alkyloxy, or the like, or a group represented by the following formula: —(CR 2a R 2b ) n —R 2c , wherein R 2a is each independently a hydrogen atom, halogen, or the like; R 2b is each independently a hydrogen atom, halogen, or the like; R 2a and R 2b which are attached to the same carbon atom may be taken together to form oxo, a substituted or unsubstituted non-aromatic carbocycle, or the like; two of R 2a which are attached to the adjacent carbon atoms and/or two of R 2b which are attached to the adjacent carbon atoms may be taken together to form a bond; R 2c is substituted or unsubstituted aromatic carbocyclyl, or the like; n is an integer from 1 to 3; R 3 and R 7 are each independently a hydrogen atom, substituted or unsubstituted alkyl, or the like; R 4 and R 5 are each independently a hydrogen atom, halogen, substituted or unsubstituted alkyl, or the like; R 6 is a hydrogen atom, halogen, substituted or unsubstituted alkyl, or the like, or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising thereof.
    本发明涉及一种由式(I)表示的化合物,其中R1是氢原子,取代或未取代的烷基,取代或未取代的芳香环烷基等;X是—N(R3)—,—O—或—S—;Y是═C(R4)—或═N—;Z是—N(R7)—,—O—或—S—;R2是取代或未取代的烷氧基等,或以下式表示的基团:—(CR2aR2b)n—R2c,其中R2a分别是氢原子,卤素等;R2b分别是氢原子,卤素等;附在同一碳原子上的R2a和R2b可以共同形成氧化物,取代或未取代的非芳香环烷基等;附在相邻碳原子上的两个R2a和/或附在相邻碳原子上的两个R2b可以共同形成键;R2c是取代或未取代的芳香环烷基等;n是1到3的整数;R3和R7分别是氢原子,取代或未取代的烷基等;R4和R5分别是氢原子,卤素,取代或未取代的烷基等;R6是氢原子,卤素,取代或未取代的烷基等,或其药学上可接受的盐,或包含其的药物组合物。
  • TRIPEPTIDE EPOXY KETONE PROTEASE INHIBITORS
    申请人:Onyx Therapeutics, Inc.
    公开号:US20160368946A1
    公开(公告)日:2016-12-22
    Provided herein are tripeptide epoxy ketone protease inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula (X): and pharmaceutically acceptable salts and compositions including the same. The compounds and compositions provided herein may be used, for example, in the treatment of diseases including inflammation and neurodegenerative disease.
  • US9434761B2
    申请人:——
    公开号:US9434761B2
    公开(公告)日:2016-09-06
  • US9499533B2
    申请人:——
    公开号:US9499533B2
    公开(公告)日:2016-11-22
  • Synthesis and polymerization of bridgehead-substituted bicyclobutanes
    作者:Henry Kingston Hall、Claibourne D. Smith、Elwood P. Blanchard、S. C. Cherkofsky、J. B. Sieja
    DOI:10.1021/ja00730a022
    日期:1971.1
查看更多